Colorectal Cancer News and reporting on colorectal cancer. Aug 5, 2022 Guardant Health Shares Details on MRD Reimbursement, Early Detection Trial Premium Aug 3, 2022 Exact Sciences Reaps Q2 Rewards From Growth in Colon Cancer Screening Premium Aug 2, 2022 Guardant Health Receives Medicare Coverage for MRD Liquid Biopsy in Stage II and III Colon Cancer Jul 28, 2022 Aniling Gets CE-IVD Marks for Cancer Sequencing Tests Jun 9, 2022 Morgan and Mendel Genomics Developing Diagnostic Tests for Cancer-Related Variant Detection Premium Jun 7, 2022 Circulating Tumor DNA Utility in Post-Surgery Stage II Colon Cancer Cemented by New Data Premium May 27, 2022 DoMore Diagnostics Obtains CE Mark for AI Algorithm to Predict Colorectal Cancer Patient Outcomes May 23, 2022 New Horizon Health, Prenetics to Launch Colorectal Cancer Test in Hong Kong, Macau, Taiwan May 19, 2022 Mainz Biomed, Dante Labs Partner to Commercialize ColoAlert in Europe, UAE May 9, 2022 Guardant Health Confident in New CRC Screening Blood Test Despite Competitor Skepticism Premium Apr 28, 2022 As Competing Blood-Based Cancer Screening Tests Loom, Exact Sciences Stresses Cologuard Advantage Premium Apr 26, 2022 Exact Sciences Q1 Revenues up 21 Percent Mar 30, 2022 Genetron Health Adds New Assays to Pipeline While Anticipating MRD Launch, Liver Cancer Kit Trials Premium Mar 23, 2022 Burning Rock Adds Validation Data as it Begins MRD and Early Detection Commercialization Premium Feb 17, 2022 Mainz Biomed Developing New Version of ColoAlert Assay Ahead of FDA Submission Premium Feb 14, 2022 Mainz Biomed Partners with German Regional Lab on Colorectal Cancer Test Commercialization Jan 26, 2022 Molecular Diagnostics Firm Mainz Biomed Prices $22.5M Follow-on Share Offering Jan 19, 2022 Mainz Biomed Taps DCN Dx to Aid European Study of Enhanced ColoAlert Assay Jan 5, 2022 Mainz Biomed Licenses mRNA Biomarkers for Colorectal Cancer Dec 14, 2021 Mainz Biomed, Ganzimmun Diagnostics Partner to Commercialize Colorectal Cancer Test Load More Breaking News Rady Children's, PlumCare RWE Partner to Expand WGS-Based Newborn Screening Program to Greece Roche Gets CE Mark for New Version of Rapid Test for Antibodies Against SARS-CoV-2 Broader Market Drags 360Dx Top 30 Down in September Olive Diagnostics Nabs CE Mark for Optical Urinalysis Device Top Five Articles on 360Dx Last Week: Congress and VALID Act; FDA Updates EUA Policy; and More In Brief This Week: Becton Dickinson, Bionano, Yourgene, More
